Cook’s Zilver PTX Peripheral Drug-Eluting Stent Sails Through FDA Panel
This article was originally published in The Gray Sheet
Executive SummaryCook Medical’s first-of-a-kind Zilver PTX percutaneous paclitaxel-eluting peripheral stent received unanimous and enthusiastic support from the FDA’s Circulatory System Devices panel last week.
You may also be interested in...
Recent data and study announcements in cardiac, neuro and diabetes.
Abbott’s Absolute Pro iliac stent and Enzo Biochem’s ColonSentry colorectal cancer test are among newly approved devices.
Cook is seeking add-on payments for its Zilver PTX drug-eluting peripheral stent and Zenith AAA endovascular graft in 2013, addressing related CMS questions at a Feb. 14 new-technology “town hall” meeting.